Paula Andrea Correa
About Paula Andrea Correa
Paula Andrea Correa is a Medical Manager at Bristol Myers Squibb in Colombia, with extensive experience in immunology and a strong ability for communication and teamwork.
Title and Position
Paula Andrea Correa holds the position of Medical Manager at Bristol Myers Squibb in Colombia. She has demonstrated strong abilities in communication and teamwork in her role.
Professional Experience
Paula Andrea Correa has an extensive background in the medical field. She worked at Sanofi Genzyme as an MSL Colombia-Peru from 2021 to 2022 in Bogotá, Colombia. Prior to that, she spent three years (2017-2020) at Roche as a Medical Science Liaison (MSL) in Hemato-Oncology in Colombia. Earlier, she was a PhD student at the Laboratory of Immunology and Molecular Diagnostics LIRAD and the Banco de Sangre y Tejidos de Catalunya from 2013 to 2017 in Medellin, Colombia, and a PhD student in Immunology at the Universitat Autònoma de Barcelona from 2009 to 2013. She also worked as a Graduate Research Fellow at the University of Texas Medical Branch-Pathology Department (2007-2009) and as an Investigador Asociado at Universidad de Antioquía (2006-2007). Her career began at the Corporacion para Investigaciones Biologicas-CIB, where she worked for eight years (1997-2005) as an Investigador científico.
Educational Background
Paula Andrea Correa achieved a PhD in Immunology from the Universitat Autònoma de Barcelona between 2010 and 2013. She also holds a Master's degree in Immunology from the Universitat de Barcelona attained in 2009-2010. Additionally, she earned a Master's degree in Biology with a specialization in Immunogenetics from the Universidad de Antioquia from 1999 to 2001. Her undergraduate studies were completed at the Universidad de Antioquia, where she received a degree in Microbiology and Clinical Laboratory, specializing in Immunology and Genetics, from 1993 to 1997.
Specializations and Expertise
Paula Andrea Correa's areas of expertise include the epigenetics of human T lymphocytes and the immunopathology of autoimmune diseases. She applies agile methodologies with a focus on achieving results and has shown a significant inclination towards experimentation and innovation throughout her career.